Subscribe

Bedtime Insulin and Daytime Oral Agent (BIDO) Regimen | Diabetes Mellitus

Purpose:

To start a patient on a bedtime insulin, daytime oral agent (BIDO) regimen for mild hyperglycemia.

Specialty:

Endocrinology
Clinical Laboratory

Objective:

dosage adjustments

ICD-10:

T38.3

Description:

A BIDO regimen (bedtime insulin, daytime oral agent) may be used by a patient who is still hyperglycemic while receiving an oral hypoglycemic agent.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone